As of 4:00pm ET
| -0.06 / -2.65%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +127.27% increase from the last price of 2.20.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.